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Abstract
Background: The aim of the present study was to validate the usefulness of the new octapolar multifrequency
bioelectrical impedance analysis (BIA) for assessment of appendicular skeletal muscle mass (ASM) by comparing it
with that of dual-energy X-ray absorptiometry (DXA) and to investigate the prevalence of sarcopenia in Chinese
community-dwelling elderly according to Asian Working Group for Sarcopenia (AWGS) definition.
Methods: A cross-sectional study was conducted in communities of Chengdu, China. A total of 944 community-
dwelling elderly adults aged ≥60 years were included. ASM was measured by using DXA as a criterion method
to validate a standing eight-electrode multifrequency BIA (InBody 720), followed by a further estimation of the
prevalence of sarcopenia according the AWGS definition.
Results: In the Bland-Altman analysis, no significant difference was found between DXA and BIA based on the ASM
measurements. The prevalence of AWGS-defined sarcopenia was 12.5% in the elderly women and 8.2% in the elderly men.
Conclusions: BIA is suitable for body composition monitoring (ASM) in elderly Chinese as a fast, noninvasive, and
convenient method; therefore, it may be a better choice in large epidemiological studies in the Chinese population. The
prevalence of AWGS-defined sarcopenia was approximately 10.4% and increased with age in the Chinese community-
dwelling elderly in this study.
Keywords: Sarcopenia, Elderly, Dual-energy X-ray absorptiometry, Bioelectrical impedance analysis, Appendicular skeletal
muscle, Asian Working Group for Sarcopenia
Background
Sarcopenia is the loss of muscle mass and function
(defined by muscle strength or physical performance)
with aging [1], which may result in reduced physical
capability, quality of life, falls, disabilities, morbidities,
and mortality, as well as high health care expenditure,
in older people [2, 3]. The prevalence of sarcopenia
has been reported to increase rapidly with aging [4, 5].
It was around 20% among people aged ≥65 years and
may reach 50–60% among octogenarians [6]. As China is
the most populated and fastest aging country in the world,
sarcopenia poses a great impact on Chinese populations in
the near future [7]. In 2010, the European Working Group
on Sarcopenia in Older People (EWGSOP) proposed an
operational definition and diagnostic strategy for sarcopenia
that had become the most widely used in the world [8]. In
2014, the Asian Working Group for Sarcopenia (AWGS)
also established the consensus on sarcopenia diagnosis,
which recommended a set of approaches for the measure-
ment of muscle mass, muscle strength, and physical per-
formance, and chose different cutoff values according to
the evidence derived from Asian populations. However, no
epidemiological survey has used the AWGS definition to
estimate the prevalence of sarcopenia in China.
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According to the AWGS definition, the measurable
variables include muscle mass, muscle strength (hand-
grip strength [HS]), and physical performance (gait
speed [GS]). The challenge is to determine how best
to measure them accurately, especially appendicular
skeletal muscle mass (ASM). Several techniques have
been used to assess ASM, including dual energy x-ray
absorptiometry (DXA), computed tomography (CT),
magnetic resonance imaging (MRI), and bioelectrical
impedance analysis (BIA) [9]. Solid evidence from
cadaver studies shows that DXA, MRI, and CT provide
precise and reliable measurements of SM and thus can
be considered as criterion methods for measuring
ASM in vivo [10–12]. However, certain factors such as
cost, accessibility, and the problem of radiation exposure
limit the use of whole-body imaging. By contrast, BIA,
which is based on measurements of tissue conductivity in
the study of human body composition, is relatively simple,
quick (takes only a few minutes), and noninvasive. Techno-
logical advances over the past decade include an increase in
the number of contact electrodes from 4 to 8 [13, 14], and
the use of multifrequency electrical levels to substitute the
single-frequency BIA. By using low- and high-frequency
electric currents, the multifrequency BIA methods success-
fully avoid the problems encountered in the use of primal
BIA devices. The different currents allow for the estimation
of extracellular and intracellular water, as well as tolal body
water [15].
Previous studies verified that compared with the DXA
method, multifrequency and eight-electrode BIA provides
reliable measurements of body composition in healthy
subjects and in patients with stable water levels [16, 17].
InBody 720 (Biospace, Korea) is a new multifrequency
analyzer with 4 pairs of electrodes (octapolar technology)
embedded into the handles (thumb and palm electrodes)
and floor scale (ball of foot and heel electrodes) of the
analyzer. The researcher does not need to standardize the
subject’s posture before BIA, which has the potential to
reduce measurement times and makes this instrument
ideal for epidemiological studies. Some previous studies
evaluated the accuracy of InBody 720 with different refer-
ence methods or in different populations [18–20], but
InBody 720 has not been validated for the estimation of
ASM in Chinese populations.
The first purpose of this study was to validate the
usefulness of InBody 720 for ASM by comparing it with
DXA. Its second purpose was to investigate the preva-
lence of sarcopenia according to the AWGS definition
in Chinese community-dwelling elderly.
Methods
Design
A cross-sectional survey to determine the prevalence of
sarcopenia according to the AWGS definition in a
Chinese community was conducted in two steps. First,
90 elderly volunteers (validation group) were recruited
from 3 communities in Chengdu City to undergo BIA
and DXA measurements to validate the accuracy of BIA
for estimating ASM. Second, another 854 volunteers
were recruited from the same communities with the
same inclusive criterion, and the prevalence of sarcopenia
in elderly people living in the community was investigated.
The study staff was well trained in using investigation
manuals, multimedia materials, and simulated patients.
The trained interviewers collected the data from all the
study participants at community centers by using face-to-
face interviews. In the validation group, the BIA and DXA
measurements were performed within 1–3 days. All the
subjects refrained from alcohol intake for at least 48 h,
from vigorous exercise for at least 12 h, and from taking a
meal or drink for at least 12 h.
Participants
We recruited 944 subjects (462 men and 482 women)
aged 60 to 92 years who voluntarily participated in the
study, through leaflets and posters provided by the Center
of Gerontology and Geriatrics, West China Hospital,
Sichuan University, between March 2014 and October
2014. Volunteers were excluded if they had any diseases
such as hyperthyroidism or hypothyroidism, or chronic
heart and renal failure, or been receiving prescribed
medications such as long-term steroid treatment, which
is known to affect body composition. Individuals who
could not communicate with the interviewers owing to
severe cognitive impairment, mental disorders, and
severe hearing and eye problems were also excluded
from the study. All the participants were ambulatory
without physical disability or amputation. The study was
approved by the ethics committee of Sichuan University,
under reference No. 2014 (57). Written consent was
obtained from each participating subject prior to testing.
Anthropometric measurements
Each subject was interviewed by using a structured
questionnaire to obtain basic demographic data and
information on medical conditions. Weight and height
were measured while barefoot and wearing light clothing.
Body weight was measured to the nearest 0.1 kg. Height
was measured with a hypsometer to the nearest 0.1 cm.
Body mass index (BMI) was calculated as weight in
kilograms divided by height in meters squared.
Muscle strength and gait speed
Muscle strength was assessed based on HS, measured by
using a dynamometer (CAMRY EH101, CHINA). The
participants were asked to exert maximum effort in a
standing position, three readings were taken from each
side, and the maximum value from the dominant hand
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was used for the analysis. Low handgrip strength was
defined as <26 kg for men and <18 kg for women. The
usual gait speed (m/s) on a 6-m course was used as an
objective measure of physical performance. The partici-
pants were asked to walk 6 m at their usual pace, and
the time required to walk the distance was measured to
calculate gait speed (m/s). Use of a cane or walker was
permitted if the participants could not perform the gait
test without it. The gait test was performed twice, and
the mean value was used in the analysis. Slow walking
speed was defined as a walking speed of ≤ 0.8 m/s.
Dual-energy X-ray absorptiometry
All the measurements were performed after overnight
fasting and abstinence from alcohol and moderate to
intensive exercise for more than 8 h. The participants in
validation group performed anthropometric measure-
ments, DXA, and BIA on the same day. Each participant
was scanned by using DXA (iDXA GE, USA) for meas-
uring appendicular muscle mass. For the imaging exam-
ination, the participants wore cotton clothing without
any metal attachments. Scans were performed in the
whole-body scan mode in the following order: head,
upper limbs, lower limbs, and trunk. Each participant
underwent approximately 20 min of whole-body scan.
Results were analyzed with software (12.10.017, GE, US).
Bioelectrical impedance analysis
Bioelectrical resistance was measured by using Inbody720
(Biospace, Korea) at frequencies of 5, 50, 250, and 500 kHz.
This instrument uses eight tactile electrodes, with four in
contact with the palm and thumb of both hands and the
other four in contact with the anterior and posterior
aspects of the sole of both feet. The subject stands
with the soles in contact with the foot electrodes and
grabs the hand electrodes. The sequence of the mea-
surements, controlled by a microprocessor, reports on
the screen and paper. No precaution was taken to
standardize the subject’s posture before BIA, as suggested
by the manufacturer. RI values were calculated at all
frequencies. Data output, as calculated by using the
manufacturer’s algorithm, included fat mass and skeletal
muscle mass of the total body, arms, and legs.
Diagnosis of sarcopenia
Sarcopenia was defined according to the AWGS algo-
rithm, in which the patient has low muscle mass, and low
muscle strength or low physical performance. As sug-
gested by the AWGS, low muscle mass was defined as
an ASM index (ASMI, ASM/height2) of <7.0 kg/m2 in
men and <5.7 kg/m2 in women. Low muscle strength
was defined as a handgrip strength of <26 kg in men
and <18 kg in women; and low physical performance,
as a gait speed of <0.8 m/s.
Statistical analyses
All statistical analyses were performed by using SPSS
version18.0 for Windows (IBM Corp, Armonk, NY).
Baseline characteristics were compared between the
men and women in the validated and elderly groups by
using an independent-samples t test for continuous vari-
ables and the Pearson chi-square test or Fisher exact test
(for which an expected cell count was <5) for categorical
variables. Pearson correlations were performed to examine
the relationship between the DXA- and the InBody
720-measured ASMs. Bland-Altman analyses were per-
formed to evaluate the extent of agreement between
both methods. The differences in the continuous variables
were compared by using one-way analysis of variance
(ANOVA). Frequency data were compared by using the
Pearson chi-square test or Fisher exact test (for which an
expected cell count was <5). Differences were considered
significant at p < 0.05.
Results
The characteristics of the subjects
Table 1 lists the characteristics of the elderly participants
according to sex. The mean age and BMI in the vali-
dated and elderly groups were respectively 68.71 ± 6.60
and 68.76 ± 6.65 years, and 24.27 ± 3.25 and 23.88 ± 3.05
(p > 0.1). We did not find significant sex-related differ-
ences in BMI and age. Although the weight and BMI in
the elderly male group were smaller than those in the
validated group (p < 0.05), the differences were not
clinically significant. The sex-related differences in each an-
thropometric variable (expect BMI) were significant in both
the validated and older groups. The men were taller and
heavier, and had higher ASM and ASMI (p < 0.001). For
physical performance, the men had significant stronger HS
in both groups (35.50 ± 7.38 vs. 23.29 ± 4.12 and 36.58 ±
7.08 vs. 23.47 ± 4.58, respectively; p < 0.001) and walked a
little faster than the women in the elderly group (1.08 ±
0.20 vs. 1.02 ± 0.18, p < 0.001). The percentages of current
alcohol drinkers and smokers were 42.4 and 28.0% in the
men, and 12.5 and 2.7% in the women, respectively. The
most prevalent medical diseases were hypertension (43.5%)
and diabetes (19.0%). No significant sex-related difference
or differences between the validated and elderly groups
were observed. The incidence rates of the remaining
medical diseases were all <5%.
Correlation between BIA- and DXA-measured ASM
The correlation between ASM obtained by using BIA and
DXA was high in both the men and women (Figs. 1a and
2a). The Pearson correlation coefficient and standard error
of the estimate (SEE) of the regression equation were 0.94
and 1.05 kg in the men, and 0.90 and 0.93 kg in the women,
respectively (both p > 0.05). No significant method-related
biases were found. The agreement of these two methods in
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the Bland-Altman analysis is presented in Figs. 1b and 2b.
Only 2 points were outside the limit of agreement in the
men; and 3 points, in the women.
Differences in body composition, muscle strength, and
physical function according to age and sex
The differences in body composition, physical functions
(represented by GS), and muscle strength (represented
by HS) according to age and sex are shown in Table 2.
ASM, ASMI, GS, and HS all showed significant declines
with age in both sexes (p < 0.005).
Estimated prevalence of low SM, low HS, low GS, and
sarcopenia in the different age groups and the elderly
group
The estimated prevalence of low SM, low HS, low GS,
and sarcopenia in the different age groups and the elderly
group are shown in Table 3. The criteria, including low
SM, low HS, low GS, and sarcopenia, were defined by the
AWGS [2]. The prevalence rates of low SM, low HS, and
low GS increased significantly with age (p < 0.001). When
the AWGS criteria were used to define sarcopenia, the
prevalence rates of sarcopenia were 2.3, 5.6, and 19.9% in
all the participants aged 60–64, 65–74, and ≥75 years,
respectively (p < 0.001), and the age-related trend was also
apparent in both sexes (p < 0.001). The prevalence rates of
sarcopenia were 8.2, 12.5, and 10.4% in the elderly women,
men, and both sexes, respectively.
Discussion
MRI, CT, and DXA measurements of ASM are not suitable
for large-scale surveys on sarcopenia in the elderly due to
cost, accessibility, and the problem of radiation exposure.
BIA might be a good alternative method to measure ASM
for epidemiological surveys. However, a previous study
reported that BIA equations chosen should not be used
without prior verification against reference methods in the
Table 1 Comparison of baseline characteristics between the
validated group and the elderly group
Validated group Elderly group p value
n mean ± SD n mean ± SD
Age (year) M 46 69.85 ± 7.03 419 69.10 ± 6.59 0.267
F 47 67.89 ± 6.11 435 68.52 ± 6.44 0.524










Weight (kg) M 43 67.14 ±
10.70
419 64.01 ± 9.16 0.037
F 47 55.32 ± 7.70 435 56.02 ± 8.64 0.594
BMI (kg/m2) M 43 24.93 ± 3.11 419 23.72 ± 2.83 0.009
F 47 23.66 ± 3.28 435 24.04 ± 3.25 0.451
GS (m/s) M 43 1.07 ± 0.19 418 1.08 ± 0.20 0.827
F 47 1.03 ± 0.15 435 1.02 ± 0.18 0.708
HS (kg) M 43 35.50 ± 7.38 419 36.58 ± 7.08 0.346
F 47 23.29 ± 4.12 435 23.47 ± 4.58 0.792
ASM (kg)
BIA M 43 19.72 ± 2.85 419 19.63 ± 2.95 0.830
F 47 13.86 ± 2.25 435 14.02 ± 2.36 0.667
DEXA M 43 18.74 ± 3.16 0 *
F 47 13.37 ± 2.13 0 *
ASMI (kg/m2)
BIA M 43 7.32 ± 0.69 419 7.26 ± 0.75 0.591
F 47 5.89 ± 0.66 435 5.99 ± 0.72 0.379
DEXA M 43 6.95 ± 0.87 0 *
F 47 5.70 ± 0.77 0 *
Medical diagnoses
Hypertension M 43 19 (44.2) 419 178 (42.5) 0.830
F 47 18 (38.3) 435 196 (45.2) 0.368
Diabetes M 43 6 (14.0) 419 82 (19.6) 0.372
F 47 10 (21.3) 435 82 (18.9) 0.688
Thyroid diseases M 43 0 419 2 (0.5) 1.000
F 47 0 435 4 (0.9) 1.000
Cardiac diseases M 43 1 (2.3) 419 23 (5.5) 0.373
F 47 7 (14.9) 435 20 (4.6) 0.004
Renal diseases M 43 0 419 6 (1.4) 1.000
F 47 2 (4.3) 435 7 (1.6) 0.216
Stroke M 43 0 418 4 (1.0) 1.000
F 47 0 434 5 (1.2) 1.000
Cancer M 43 1 (2.3) 419 3 (0.7) 0.324
F 47 0 435 2 (0.5) 1.000
COPD M 43 0 419 5 (1.2) 1.000
F 47 1 (2.1) 435 7 (1.6) 0.563
Tuberculosis M 43 0 419 9 (2.1) 1.000
Table 1 Comparison of baseline characteristics between the
validated group and the elderly group (Continued)
F 47 0 435 1 (0.2) 1.000
Hepatic diseases M 43 1 (2.3) 419 8 (1.9) 0.588
F 47 0 435 7 (1.6) 1.000
Smoking habits M 43 12 (27.9) 419 118 (28.2) 0.972
F 47 0 435 13 (3.0) 0.626
Alcohol
consumption
M 43 24 (55.8) 419 173 (41.3) 0.067
F 47 12 (25.5) 435 48 (11.1) 0.004
*: no data; BMI body mass index, GS gait speed, HS handgrip strength, ASM
appendicular skeletal muscle mass, ASMI appendicular skeletal muscle mass
index, BIA bioelectrical impedance analysis, DXA dual energy x-ray absorptiometry,
COPD chronic obstructive pulmonary disease; Using independent-samples t test for
continuous variables and Pearson chi-square or Fisher exact test (where an
expected cell count was < 5) for categorical variables. During testing, p < 0.05
was considered statistically significant
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subject population studied because of existing differences
in body build among ethnic groups [21]. To the best of our
knowledge, this is the first study that validated the useful-
ness of a multifrequency octapolar BIA, InBody 720, and its
predictive ability for estimating ASM by comparing it with
those of DXA in community-dwelling elderly people in
China. The results of the present study demonstrated the
Pearson correlation coefficients (0.944 and 0.903) and SEE
(1.051 and 0.927 kg) in men and women, respectively, in
predicting ASM, which were similar to those obtained in
previous reports [16, 22, 23]. Houtkouper et al. suggested
that prediction errors (SEE) of 2.0–2.5 kg in men and
1.5–1.8 kg in women are considered ideal [21]. Although
the negative slope of the Bland-Altman plot indicated a
trend of underestimation and overestimation errors with
the BIA method for participants with lower and higher
ASMs, respectively, the mean error was small and
insignificant. Thus, this result suggests that the BIA
method provided a meaningful ASM estimation in the
Chinese populations. However, our observation conflicts
with the results of Anderson et al., who found a significant
InBody 720 underestimation of ASM in men (−3.0 kg)
Fig. 1 a Regression between the bioelectrical impedance analysis
(BIA)-measured and Dual-energy X-ray absorptiometry (DXA)-measured
appendicular skeletal muscle mass (ASM) in males. Solid line, regression
line. b Bland-Altman plot for difference between DXA-measured and
BIA-measured ASM and the average ASM of the two methods in males.
Solid line represents the mean difference (−0.99 kg); Outer dotted lines
represent limits of agreement (−3.05 to 1.06 kg) (95% confidence
interval). r2 = coefficient of determination; SEE = standard error of
the estimate
Fig. 2 a Regression between the bioelectrical impedance analysis
(BIA)-measured and Dual-energy X-ray absorptiometry (DXA)-measured
appendicular skeletal muscle mass (ASM) in females. Solid line, regression
line. b Bland-Altman plot for difference between DXA-measured and
BIA-measured ASM and the average ASM of the two methods in
females. Solid line represents the mean difference (−0.49 kg); Outer
dotted lines represent limits of agreement (−2.40 to 1.41 kg) (95%
confidence interval). r2 = coefficient of determination; SEE = standard
error of the estimate
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and women (−1.0 kg) [24]. Their study population was
quite different from ours; their subjects were not
Asians, were aged 18 to 49 years, and had slightly
higher BMIs (25.8 ± 4.5 kg/m2). Another study conducted
in a Finnish population found that compared with DXA,
InBody 720 provided on average 2–6% lower values for fat
mass (FM) in men with normal BMI and in all BMI cat-
egories in women. However, the authors did not report
the correlation of ASM. But in our recent research, we
did not validate the correlation according to BMI
categories.
Association of sarcopenia with poor health status and
adverse outcomes had triggered a new approach for health
promotion and health care of older people. Nutrition and
exercise interventions can help prevent age-related decline
in physical performance and increase in mortality [25, 26].
Although the prevalence of sarcopenia in elderly people
has been broadly investigated in Asia, the large variability
in prevalence is partly related to the differences in mea-
surements and cutoffs used to define sarcopenia. Hence,
the AWGS developed a consensus definition and cutoff
points for sarcopenia in Asia. To our knowledge, this is the
first large epidemiological survey that used the AWGS
definition to estimate the prevalence of sarcopenia in
Chinese community-dwelling elderly. The results show
prevalence rates of 12.5% and 8.2% in women and men,
respectively. The prevalence of sarcopenia varies across
studies because of different study populations, ages,
sex, and diagnosis criteria [25]. Focusing on the Chinese
elderly, between-study variations in the prevalence of
sarcopenia also exists. We found only 3 studies that used
the AWGS definition in Chinese elderly. One study is
currently conducted in Chinese suburb-dwelling elderly,
and the authors reported that the prevalence of sarcopenia
was 11.5% in women and 6.4% in men [27], which were
similar to the outcomes in our study. Another research
study found that the prevalence rates of sarcopenia (using
the AWGS definition) were 5.9% in men and 0.7% in
women [18], which were much lower than ours. Their
research only included 286 participants with a mean age
of 66.5 ± 4.8 years in men and 65.4 ± 4.5 years in women.
The difference in age partly resulted in the diversity of
prevalence. Another study reported that the prevalence
rates of AWGS-defined sarcopenia were 7.0 and 13.1% in
Chinese urban and rural elderly, respectively. These values
indicate a significant difference, which was partly due
Table 2 Differences in body composition, muscle strength and physical function with age and gender
Age group (year) Number ASM (kg) ASMI (kg/m2) HS (kg) GS (s)
Males 60–64 146 20.24 ± 0.26 7.43 ± 0.06 39.62 ± 0.54 1.12 ± 0.02
65–74 200 19.55 ± 0.20 7.23 ± 0.05 36.64 ± 0.46 1.09 ± 0.01
≥75 117 19.03 ± 0.27 7.09 ± 0.07 32.21 ± 0.63 0.99 ± 0.02
p 0.003 0.001 <0.001 <0.001
Females 60–64 162 14.55 ± 0.18 6.10 ± 0.06 25.06 ± 0.35 1.08 ± 0.01
65–74 226 14.13 ± 0.15 6.03 ± 0.05 23.40 ± 0.28 1.02 ± 0.01
≥75 94 12.76 ± 0.22 5.67 ± 0.07 20.80 ± 0.44 0.92 ± 0.02
p <0.001 <0.001 <0.001 <0.001
ASM appendicular skeletal muscle mass, ASMI appendicular skeletal muscle mass index, HS handgrip strength, GS gait speed, Using one-way ANOVA for continuous
variables. During testing, p < 0.05 was considered statistically significant
Table 3 Estimated prevalence of low SM, low HS, low GS and sarcopenia in different age groups and the elderly
Age group (year) Number Low muscle mass Low gait speed Low handgrip strenth Sarcopenia
Male 60–64 146 40 (27.4) 4 (2.7) 5 (3.4) 4 (2.7)
65–74 199 68 (34.2) 9 (4.5) 4 (2.0) 8 (4.0)
≥75 117 52 (44.4) 18 (15.4) 20 (17.1) 18 (15.4)
elderly 316 120 (38.0) 27 (8.6) 24 (7.6) 26 (8.2)
p 0.015 <0.001 <0.001 <0.001
Female 60–64 162 20 (12.3) 6 (3.7) 6 (3.7) 3 (1.9)
65–74 226 37 (16.4) 17 (7.5) 17 (7.5) 16 (7.1)
≥75 94 36 (38.3) 22 (23.4) 25 (26.2) 24 (25.5)
elderly 320 73 (22.8) 39 (12.2) 42 (13.1) 40 (12.5)
p <0.001 <0.001 <0.001 <0.001
Low muscle mass was defined as appendicular skeletal muscle mass index (ASMI) <7 kg/m2 for males and <5.7 kg/m2 for females; low gait speed (GS) as GS <0.8 m/s;
low handgrip strength (HS) as HS <26 kg for males or <18 kg for females. Using Pearson chi-Square tests or Fisher exact test (for which an expected cell count was <5)
for categorical variables. Comparison between 60-64, 65-74, and ≥75, p < 0.05 was considered statistically significant
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to underdevelopment of living and socioeconomic con-
ditions in rural areas. However, the researchers applied only
anthropometric measures for estimating skeletal muscle
mass instead of BIA or DXA [28]. Some studies also inves-
tigated the prevalence of sarcopenia in Chinese popula-
tions by using different diagnostic criteria. According to
a large cohort study involving 4000 Chinese community-
dwelling adults aged ≥65 years in Hong Kong, the preva-
lence of sarcopenia (defined by the EWGSOP criteria) was
9% at baseline [29], which was similar to the outcome in
our study. However, a survey in Taiwan found that the
prevalence (defined by a BMI of 8.87 kg/m2 in men and
6.42 kg/m2 in women) of sarcopenia was 18.6% in women
and 23.6% in men, which were much higher than our re-
sults. It also reported a great discrepancy in prevalence of
sarcopenia, from 14 to 37% in women and from 13 to 42%
in men, in the same sample depending on the definition
used [5]. The tremendous variations within the same popu-
lation shown in the previous research studies bring into
question the results of the existing studies on sarcopenia
prevalence. These variations were partly due to the different
participants and definitions of sarcopenia. Furthermore, the
appropriate definition of sarcopenia in Chinese older adults
remains unclear [30, 31]. Therefore, large population-based
perspective surveys are required for Chinese people to
establish ethnic-specific references and cutoff values for
older adults [32].
Similar to those of other authors [4, 30, 33, 34], our
present findings also confirmed the decrease in ASM,
ASMI, HS, and GS, and the increase in the prevalence
rates of low muscle mass, low muscle strength, and low
physical performance with age. We observed that ASM
was significantly lower among the women aged ≥75 years
than among those in the preceding age group (12.76 ±
0.22 kg vs. 14.13 ± 0.15 kg, p < 0.001). Moreover, even
though ASM decreased dramatically, body weight just
decreased slightly with aging, partly due to the increase
in FM (unreported data). The decrease in ASM and
increase in FM accompanying aging may lead to the
development of sarcopenia and contribute to obesity
in the elderly [33]. We also found that muscle strength
(HS) and physical performance (GS) decreased more
greatly with age than did muscle mass (p < 0.001), which
was similar to the findings of previous cross-sectional or
longitudinal investigations [30, 35–38]. Goodpaster found
that even maintenance or gain of lean mass in the elderly
did not prevent loss of strength [39]. Despite extensive
research efforts, the mechanism responsible for the
age-associated decline in muscle strength has not been
completely elucidated, but the age-associated decline in
muscle mass certainly plays a partial role [38]. Muscle
strength, rather than muscle mass, is more important
in estimating adverse outcomes such as physical disability,
poor quality of life, and higher mortality [39–41]. For this
reason, both EWGS and AWGS recommended the use of
both low muscle mass and function (strength or perform-
ance) for the diagnosis of sarcopenia [2, 8].
Study limitations
Some limitations of this study should be pointed out.
First, as previously mentioned, nonrandom selection of
the study population and the exclusion of elderly people
with severe chronic diseases from our study group might
have resulted in a selection bias. Consequently, the study
group, which included individuals who were relatively
healthy and had good activity level, might have caused,
to some extent, the underestimation of the prevalence of
sarcopenia. Second, we used DXA as the “gold standard”
reference method to validate BIA (InBody 720). Although
validation in comparison with DXA is the most feasible
and appropriate choice for our research, it is possibly not
the most accurate analysis. The sample sizes for the
Bland-Altman analysis should be more than 100; however,
in our study, we only collected 90 participants because of
the limited condition. In our future research, we should
expand the sample sizes to decrease the bias. Finally, as a
cross-sectional study, it may not provide the same results
as a longitudinal or semi-longitudinal study. This paper
presents the first-stage research results. In the next-stage
research, the change trend of muscle mass, muscle
strength, physical performance, and other outcome in-
dicators such as falls, hospital admission, and mortality
will be investigated.
Conclusion
In conclusion, the relatively high correlation coefficient
between the BIA- (InBody 720) and DXA-measured ASMs
indicates that the application is suitable for body compos-
ition monitoring in elderly Chinese in a fast, noninvasive,
and convenient way. The study also demonstrates that the
prevalence of AWGS-defined sarcopenia was approxi-
mately 10.4% and increased with age in a sample of Chinese
community-dwelling elderly.
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